scholarly article | Q13442814 |
P2093 | author name string | Milliner DS | |
Monico CG | |||
P2860 | cites work | The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II | Q22010369 |
Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I | Q24299643 | ||
Combined liver-kidney transplantation for primary hyperoxaluria type 1 in young children | Q31832605 | ||
Kidney transplantation in primary oxalosis: data from the EDTA Registry | Q33771313 | ||
Liver transplantation in children: long-term outcome and quality of life | Q33797818 | ||
Identification of missense, nonsense, and deletion mutations in the GRHPR gene in patients with primary hyperoxaluria type II (PH2). | Q33921289 | ||
Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome | Q34254765 | ||
Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure | Q36994464 | ||
Primary hyperoxaluria type I. | Q37928429 | ||
Transplantation for primary hyperoxaluria in the United States | Q42609011 | ||
Phenotypic expression of primary hyperoxaluria: comparative features of types I and II. | Q43514404 | ||
Combined hepatic and renal transplantation in primary hyperoxaluria type I: clinical report of nine cases | Q44520325 | ||
Preemptive liver transplantation from a living related donor for primary hyperoxaluria type I. | Q55067573 | ||
P433 | issue | 11 | |
P304 | page(s) | 954-963 | |
P577 | publication date | 2001-11-01 | |
P1433 | published in | Liver Transplantation | Q15730498 |
P1476 | title | Combined liver-kidney and kidney-alone transplantation in primary hyperoxaluria | |
P478 | volume | 7 |
Q46551815 | A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): the European PH1 transplant registry experience 1984-2004. |
Q38017938 | An update on primary hyperoxaluria |
Q48113340 | Bilateral native nephrectomy to reduce oxalate stores in children at the time of combined liver-kidney transplantation for primary hyperoxaluria type 1. |
Q34261036 | Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation |
Q34719077 | Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter |
Q38061207 | Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions |
Q36613873 | Hyperoxaluria and systemic oxalosis: current therapy and future directions |
Q63441488 | Hyperoxalurie primitive |
Q35574335 | Intra-operative continuous renal replacement therapy during combined liver-kidney transplantation in two patients with primary hyperoxaluria type 1. |
Q81893017 | Liquid chromatography-tandem mass spectrometry method for routine measurement of oxalic acid in human plasma |
Q38228334 | Liver-kidney transplantation in primary hyperoxaluria type-1: case report and literature review |
Q35798380 | Oxalate quantification in hemodialysate to assess dialysis adequacy for primary hyperoxaluria |
Q80124022 | Presentation and role of transplantation in adult patients with type 1 primary hyperoxaluria and the I244T AGXT mutation: Single-center experience |
Q83105908 | Restrictive cardiomyopathy in a patient with primary hyperoxaluria type II |
Q35977167 | Sustained pyridoxine response in primary hyperoxaluria type 1 recipients of kidney alone transplant |
Q83370521 | The primary hyperoxalurias |
Q34247162 | Transplantation Outcomes in Primary Hyperoxaluria |
Q38105961 | Update on oxalate crystal disease |
Search more.